MRD / Regn No. : 2347 Date : 02/07/2026
Patient Name : Soleman Mallick Age & Gender : 63 Yrs. / Male
Contact No. : 9733706311 UHID :
Ht / Wt / BMI : 167 / 74 / 26.53 BP S / BP D : 151 / 76
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (23/Mar/2000) | SEVERE NPDR (23/Mar/2023) | PTCA (08/Jan/2024) |
Plan : CONTINUE OTHER MEDICINES BY CARDIOLOGIST  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 92 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 115 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES 		SQ 0-0-38 BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + METFORMIN 1000 SR
APDA M FORTE 		PO 1-0-0 BEFORE BREAKFAST
3 ACARBOSE 50 MG + METFORMIN 500 MG
GLUCOBAY M 50/500 MG 		PO 0-1-0 BEFORE LUNCH
 TILL NEXT VISIT
4 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.25 MG
SEMAGLU 0.25 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 02/Jan/2027
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: